Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
General Relativity and Gravitation
|
September 29, 2015
Gravitational waves: search results, data analysis and parameter estimation: Amaldi 10 Parallel session C2
Pia Astone, Alan Weinstein, Michalis Agathos, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2021
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors
Emily C Cherney, Liping Zhang, Weiwei Guo, et al.
Journal of Medicinal Chemistry
|
February 21, 2019
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical Trials
John L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Journal of Medicinal Chemistry
|
October 23, 2019
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy
David Marcoux, James J-W Duan, Qing Shi, et al.
Journal of Medicinal Chemistry
|
May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders
Qingjie Liu, Qing Shi, David Marcoux, et al.
Journal of Medicinal Chemistry
|
March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain
Guanglin Luo, Ling Chen, Walter A Kostich, et al.
Journal of Medicinal Chemistry
|
February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)
Yan Shi, Ying Wang, Wei Meng, et al.
Physical Review Letters
|
August 26, 2022
Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run
R Abbott, T D Abbott, F Acernese, et al.
Physical Review Letters
|
July 2, 2021
Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run
R Abbott, T D Abbott, S Abraham, et al.
Physical Review Letters
|
February 16, 2026
Black Hole Spectroscopy and Tests of General Relativity with GW250114
A G Abac, I Abouelfettouh, F Acernese, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
General Relativity and Gravitation
|
September 29, 2015
Gravitational waves: search results, data analysis and parameter estimation: Amaldi 10 Parallel session C2
Pia Astone, Alan Weinstein, Michalis Agathos, et al.
ACS Medicinal Chemistry Letters
|
July 16, 2021
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors
Emily C Cherney, Liping Zhang, Weiwei Guo, et al.
Journal of Medicinal Chemistry
|
February 21, 2019
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical Trials
John L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Journal of Medicinal Chemistry
|
October 23, 2019
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy
David Marcoux, James J-W Duan, Qing Shi, et al.
Journal of Medicinal Chemistry
|
May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders
Qingjie Liu, Qing Shi, David Marcoux, et al.
Journal of Medicinal Chemistry
|
March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain
Guanglin Luo, Ling Chen, Walter A Kostich, et al.
Journal of Medicinal Chemistry
|
February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)
Yan Shi, Ying Wang, Wei Meng, et al.
Physical Review Letters
|
August 26, 2022
Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run
R Abbott, T D Abbott, F Acernese, et al.
Physical Review Letters
|
July 2, 2021
Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run
R Abbott, T D Abbott, S Abraham, et al.
Physical Review Letters
|
February 16, 2026
Black Hole Spectroscopy and Tests of General Relativity with GW250114
A G Abac, I Abouelfettouh, F Acernese, et al.
Page
of 10